Tumornecrosis-factor-α308 GA polymorphism in atherosclerotic patients

Pathology and Oncology Research

Volumn 17, Issue 4, 2011, Pages 853-857

  Szabó, Gábor Viktor ^a   Acsády, György ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Atherosclerosis; Cardiovascular risk; Polymorphism; Tumornecrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS; STROKE;

EID: 84855466927     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9393-8     Document Type: Article

References (23)

1. Yang Z, Ming X (2006) Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res 4 (1):53-65
2. Blanke G, Ridker P (2001) Inflammatory mechanisms in atherosclerosis: From laboratory evidence to clinical application. Ital Heart J 2(11):796-800 (Pubitemid 34041366)
3. Ablij HC, Meinders AE (2002) C-reactive protein: History and revival. Eur J Int Med 13:412-422
4. Ridker P, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E (2000) Elevation of tumor necrosis factor-alfa, and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149-2153 (Pubitemid 30253042)
5. Stenvinkel P (2001) Endothelial dysfunction and inflammation- is there a link? Nephrol Dial Transplant 16:1968-1971 (Pubitemid 32970552)
6. Shah P (1998) Role of infalammation and metalloproteinases in plaque disruption and thrombosis. Vasc Med 3:199-206 (Pubitemid 28553005)
7. Geisler T, Bhatt DL (2004) The role of inflammation in atherosclerosis: Current and future strategies of medical treatment. Med Sci Monit 10(12):308-316
8. Stoll G, Bendzus M (2006) Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization. Stroke 37:1923-1932 (Pubitemid 44297753)
9. Fiotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T, Dobrina A, Guarnieri G (1999) Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with periferial arterial disease. Atherosclerosis 145:51-60 (Pubitemid 29292700)
10. Libby P, Ridker PM, Maseri A (2002) Inflammation and Atherosclerosis. Circulation 105:1135-1143 (Pubitemid 34212626)
11. Monraats PS, Pires NMM, Schepers A, Agema W, Boesten L, Vries M, Zwinderman A, de Maat M, Doevendans P, Winter R, Tio R, Waltenberger J, Hart L, Frants R, Quax P, Vlijmen B, Havekes L, Laarse A, Wall E, Jukema W (2005) Tumor necrosis factor- a plays and important role in restenosis development The. FASEB J 19:1998-2004 (Pubitemid 41759745)
12. Dalziel B, Gosby A, Richman R, Bryson J, Caterson I (2002) Association of the TNF-α (-308 G/A) promoter polymorphism with insulin resistance in obesity. Obes Res 10(5):401-407 (Pubitemid 135688251)
13. Hotamisligil G (2006) Inflammation and metabolic disorders. Nature 444(14):860-867 (Pubitemid 46024993)
14. Nieszner E, Bárdos P, Baranyi E, Préda I (2005) A diabetes mellitus cardiovascularis szövodményei és diagnózisuk. LAM 15 (10):722-729 (Pubitemid 41527241)
15. Vendrell J, Fernandez-Real JM, Gutierrez C, Gutierrez C, Zamora A, Simon I, Bardaji A, Ricart W, Richart C (2003) A polymorphysm in the promoter of the tumor necrosis facrtor-a gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 167:257-264 (Pubitemid 36773525)
16. Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J, Richart C, Soler J, (1997) The TNF-αlpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46(9):2096-2098
17. Welt FGP, Rogers C (2002) Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 22:1769-1776 (Pubitemid 35315761)
18. Szabó GV, Kunstár A (2009) Acsády Gy.: Methylentetrahydrofolate reductase and nitric oxid synthase polymorphysm in patients with atherosclerosis and diabetes. Pathol Oncol Res 15:631-637
19. Ascer E, Bertolami M, Venturinelli M, Buccheri V, Souza J, Nicolau J, Ramires JA, Serrano C (2004) Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 177:161-166 (Pubitemid 39361151)
20. Goodwin BL, Pendleton LC, Levy MM, Solomonson LP, Eichler DC (2007) Tumor necrosis factor- a reduces argininosuccinate synthase expression and nitrix oxide production in aortic endothelial cells. Am J Physiol Heart Circ Physiol 293:1115-1121
21. Wilson AG, Symons JA, McDowell TL, McDevitt H (1997) Effects of a polymorphismin the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199 (Pubitemid 27157287)
22. Herrmann SM, Ricard S, Nicaud V, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F (1988) Polymorphisms of the tumour necrosis factir- a gene, coronary heart diseases and obesity. Eur J Clin Invest 92:14-8
23. Elkind MS, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H, Rabbani LE, Sacco RL (2002) Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 33:31-38